A pharma firm headquartered in Europe, with offices in the U.S. and across Europe, forms in-licensing relationships and partnerships with development-stage pharmaceutical companies. The firm is open to partnering with companies globally.
The firm is focused on hematology-oncology, and sleep disorders. The firm is also interested in reviewing assets in pediatric oncology, niche areas of CNS and other rare disorders, particularly pediatric diseases. The firm generally prefers that assets that have obtained proof of concept in humans, but may look at earlier stage opportunities in the firm’s key areas of hematology-oncology or sleep disorders.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org